CEO Council members urge Washington to support the removal of restrictions on PHL to allow the region to again serve as an entry point to our nation for transatlantic air service.
Two virtual programs held in June featured cell & gene therapy and health care experts from the region as they spotlighted R&D for two important topics: cancer and the novel coronavirus.
Greater Philadelphia is a center of excellence in cell and gene therapies. This article originally appeared in Site Selection Magazine's July 2020 edition.
Study Projects Future Workforce Talent Needs for Cell & Gene Therapy Sector and Benchmarks Connected Health Sector in Greater Philadelphia
PHILADELPHIA (May 13, 2020) – An independent study to analyze the current workforce landscape and assess the future talent needs of the Greater Philadelphia region’s cell and gene therapy and connected health sectors has found that this workforce is expected to grow between 35 percent to 94 percent in the next 10 years using mid-range growth estimates. The growth could be as much as 54 percent to 136 percent using high-range growth estimates.
With support from The Lenfest Foundation, three organizations – the Chamber of Commerce for Greater Philadelphia’s regional CEO Council for Growth, the University City Science Center, and University […]
Greater Philadelphia Region’s Health Care and Life Sciences Organizations Contribute to Coronavirus Response
PHILADELPHIA (May 8, 2020) – Greater Philadelphia’s health care, science, and research institutions have quickly shifted resources and priorities to mobilize and make a difference in the fight against COVID-19. From working to develop a vaccine against SARS-CoV-2 to investigating the capacity of CRISPR molecules to diagnose or treat COVID-19, the health care and life sciences community is making significant contributions to the COVID-19 response. Educational institutions and corporations are also employing technology to benefit frontline health care workers as they engineer, collect, and donate personal protective equipment including masks and respirators. Connected health technology is rapidly expanding, and companies […]
The Wistar Institute of Philadelphia and Inovio Pharmaceuticals of Plymouth Meeting Are Part of Team Seeking COVID-19 Vaccine
The local organizations join a collaboration funded by the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to the vaccines during outbreaks.
Big4Bio, which added Philadelphia to their geographic coverage areas in June 2019, recently debuted it first Year in Review report for our region.
Greater Philadelphia Region Celebrates Momentum in Cell and Gene Therapy, Gene Editing, and Connected Health: 2019 in Review
The Greater Philadelphia region’s health care and life sciences community has much to celebrate as 2019 concludes.
Experience, talent, resources to fund research, willingness of people to help each other - these are some of traits of the Greater Philadelphia region as described by leaders in cell and gene therapy, gene editing, & connected health in two videos promoting the region’s leadership role in these sectors.
The PACT 2018 Philadelphia Venture Report is now available, powered by PitchBook Data and breaking down all key trends in the Philly MSA from last year.
For the fifth year in a row, the Philadelphia MSA venture ecosystem closed in on nearly 200 transactions. However, 2018 set its own record, seeing nearly $1.4 billion invested—eclipsing the prior high of $1.1 billion handily. Median financing sizes also remained relatively healthy as opposed to inflated, signifying a sustainable financing environment. Although larger rounds are occurring more frequently than in the past, as over 60% of all capital invested in the Philly MSA in 2018 was […]